Skip to main content
. 2021 Oct 26;15:751643. doi: 10.3389/fnins.2021.751643

Figure 5.

Figure 5

Surface under the cumulative ranking curve (SUCRA) of the rest of drugs after excluding cabergoline. (Gab, Gabapentin; GabE, Gabapentin enacarbil; L-DP, Levodopa; Rot, Rotigotine; Ppx, Pramipexole; Cab, Cabergoline; Rop, Ropinirole; Preg, Pregabalin; Oxy-Na, Oxycodone-naloxone; Pla, Placebo).